Chinese patient medicament for treating cardiovascular and cerebrovascular diseases

Abstract

The invention relates to a Chinese patient medicament for treating cardiovascular and cerebrovascular diseases and a preparation method thereof. The Chinese patient medicament is prepared from the following raw materials by weight: 0.3 gram of cornu saigae tatariace powder, 12 grams of tabasheer, 15 grams of grassleaf sweelflag rhizome, 15 grams of sea-ear shell, 10 grams of nacre, 15 grams of raw dragon bone and oyster shell, 12 grams of thinleaf milkwort root-bark, 12 grams of bamboo shavings, 20 grams of salivia chinensis, 15 grams of tall gastrodia tuber, 20 grams of gambir plant, 20 grams of common selfheal fruit-spike, 10 grams of radix geutianae, 20 grams of dendrobium, 30 grams of liquor white paeony root, 30 grams of vinegar white paeony root, 30 grams of raw white paeony root, 12 grams of radix curcumae, 15 grams of vinegar Chinese thorowax root, 15 grams of liquor rhubarb, 0.1 gram of musk, 12 grams of turtle shell, 15 grams of stiff silkworm, 20 grams of sanguisuga, 30 grams of earthworm, 25 grams of kudzuvine root, 10 grams of scorpion, 15 grams of desertliving cistanche, 6 grams of liquorice root, 100 grams of astragalus, 15 grams of szechwon tangshen root, 20 grams of heterophylly falsestarwort root, 15 grams of liquor Chinese angelica, 12 grams of szechuan lovage rhizome, 12 grams of safflower and the like. The Chinese patient medicament has the advantages of preventing the evolution period and sequelae of the cardiovascular and cerebrovascular diseases from generating and overcoming the defect that other treatment methods make patients generate medicinal tolerance to various medicaments.

Description

technical field [0001] The invention relates to a Chinese patent medicine for treating cardiovascular and cerebrovascular diseases. Background technique [0002] At present, cardiovascular and cerebrovascular diseases have become the world's largest health killer and one of the important diseases that threaten human life. The number of people who suffer from the disease is still expanding, and the age of onset is gradually getting younger, the incidence rate is high, and the disability rate is high. , high mortality and high recurrence rate. China has entered the status quo of aging. For this reason, there are a lot of prescriptions and medicines for developing and treating cardiovascular and cerebrovascular diseases, such as Xinnaokang and Naoxintong, which are sold on the market, all have good curative effects, but through clinical observation, although the above-mentioned medicines have no effect on cardiovascular and cerebrovascular diseases. It has a good effect, but ...

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a kind of Chinese patent medicine for treating cardiovascular and cerebrovascular diseases, prevent the development of cardiovas

Images